多普勒内镜探头血流监测改善严重非静脉曲张性上消化道出血患者的风险分层与结局
这项在2个转诊中心开展的单盲随机对照试验纳入148例严重非静脉曲张性上消化道出血患者(125例溃疡、19例Dieulafoy病变、4例Mallory-Weiss撕裂),比较标准肉眼引导内镜止血与多普勒血流监测辅助内镜止血。结果显示,多普勒组30天内病变再出血率为11.1%,低于对照组的26.3%(P = .0214),多普勒监测再出血的比值比为0.35(95%CI 0.143-0.8565),需治疗人数为7。作者认为指南应纳入这些结果。
要点
- 多普勒探头引导内镜止血较标准肉眼引导显著降低30天再出血率(11.1% vs 26.3%,P = .0214)。
- 多普勒监测再出血的比值比为0.35(95%CI 0.143-0.8565),需治疗人数为7。
- 研究纳入严重非静脉曲张性上消化道出血患者,包括溃疡、Dieulafoy病变和Mallory-Weiss撕裂。
核心结论
- 在因溃疡或其他病变导致严重上消化道出血的患者中,多普勒探头引导内镜止血较标准肉眼引导内镜止血显著降低30天再出血率。
- 作者认为非静脉曲张性消化道出血指南应纳入这些结果。
研究设计与样本
- 单盲随机对照试验,在2个转诊中心开展,共纳入148例严重非静脉曲张性上消化道出血患者。
- 患者包括125例溃疡、19例Dieulafoy病变和4例Mallory-Weiss撕裂,随机分为标准肉眼引导内镜止血组(对照组,n = 76)和多普勒血流监测辅助内镜止血组(n = 72)。
- 主要结局为30天后再出血率,次要结局为并发症、死亡及输血、手术或血管造影需求。
主要发现
- 内镜止血后30天内病变再出血率对照组为26.3%,多普勒组为11.1%,差异有统计学意义(P = .0214)。
- 多普勒监测再出血的比值比为0.35(95%CI 0.143-0.8565),需治疗人数为7。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: For 4 decades, stigmata of recent hemorrhage in patients with nonvariceal lesions have been used for risk stratification and endoscopic hemostasis. The arterial blood flow that underlies the stigmata rarely is monitored, but can be used to determine risk for rebleeding. We performed a randomized controlled trial to determine whether Doppler endoscopic probe monitoring of blood flow improves risk stratification and outcomes in patients with severe nonvariceal upper gastrointestinal hemorrhage. METHODS: In a single-blind study performed at 2 referral centers we assigned 148 patients with severe nonvariceal upper gastrointestinal bleeding (125 with ulcers, 19 with Dieulafoy's lesions, and 4 with Mallory Weiss tears) to groups that underwent standard, visually guided endoscopic hemostasis (control, n = 76), or endoscopic hemostasis assisted by Doppler monitoring of blood flow under the stigmata (n = 72). The primary outcome was the rate of rebleeding after 30 days; secondary outcomes were complications, death, and need for transfusions, surgery, or angiography. RESULTS: There was a significant difference in the rates of lesion rebleeding within 30 days of endoscopic hemostasis in the control group (26.3%) vs the Doppler group (11.1%) (P = .0214). The odds ratio for rebleeding with Doppler monitoring was 0.35 (95% confidence interval, 0.143-0.8565) and the number needed to treat was 7. CONCLUSIONS: In a randomized controlled trial of patients with severe upper gastrointestinal hemorrhage from ulcers or other lesions, Doppler probe guided endoscopic hemostasis significantly reduced 30-day rates of rebleeding compared with standard, visually guided hemostasis. Guidelines for nonvariceal gastrointestinal bleeding should incorporate these results. ClinicalTrials.gov no: NCT00732212 (CLIN-013-07F).
引用
- Jensen DM, Kovacs TOG, Ohning GV, et al. Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage. Gastroenterology. 2017. PMID: 28167214. doi:10.1053/j.gastro.2017.01.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。